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Accidental  freezing  of  vaccines  is  a growing  threat  and  a real  risk  for national  immunization  programs
when  the potency  of  many  vaccines  can  be  compromised  if these  are  exposed  to sub-zero  temperatures  in
the cold  chain.  In Tunisia,  this  issue  is compounded  by using  sub-standard  domestic  cold  chain  equipment
instead  of equipping  the  program  with  medical  refrigerators  designed  speciﬁcally  for  storing  vaccines
and  temperature  sensitive  pharmaceuticals.  Against  this  backdrop,  this  paper  presents  the ﬁndings  of  a
demonstration  project  conducted  in  Tunisia  in  2012  that  tested  the impact  of introducing  several  freeze
prevention  solutions  to mitigate  the risk  of accidental  freezing  of  vaccines.  The main  ﬁnding  is  that,
despite  the  continued  use of  underperforming  domestic  refrigerators,  continuous  temperature  monitor-
ing using  new  technologies  combined  with other  technological  interventions  signiﬁcantly  reduced  the
prevalence  of accidental  exposure  to  freezing  temperatures.  These  improvements  were  noticed  for  cold
chain storage  at  regional,  district  and  health  center  levels,  and  during  the  transport  legs  that  were  part
of  the  demonstration  conducted  in  the  regions  of Kasserine  in  the South-Eastern  part  of  Tunisia.  Subse-
quent  to introducing  these  freeze  prevention  solutions,  the  incidence  of  freeze  alarms  was  reduced  and
the  percent  of time  the  temperatures  dropped  below  the  2 ◦C  recommended  threshold.  The  incidence  of
freeze  alarms  at  health  center  level  was  reduced  by 40%.  Lastly,  the  solutions  implemented  reduced  risk
of freezing  during  transport  from  13.8%  to  1.7%.  Although  the  solution  implemented  is  not optimal  in the
longer  term  because  domestic  refrigerators  are  used  extensively  in  district  stores  and  health  centers,  the
risk of  accidental  freezing  is  signiﬁcantly  reduced  by  introducing  the practice  of continuous  temperature
monitoring  as a standard.  The  management  of the  cold  chain  equipment  was  strengthened  as a  result
which  helps  protect  the potency  of  vaccines  to the  areas  of  most  difﬁcult  access.
ublis©  2014  The  Authors.  P
. Introduction
Some immunization programs in the world may  be vaccinat-
ng their population with vaccines that have lost their potency
1] due to cold rather than heat as the better-known hazard. Vac-
ine freezing is a known problem in many countries [2,3] and in
unisia the need to ﬁnd a solution was triggered by three key con-
erns. Firstly, an effective vaccine management evaluation (EVM
4]) included a small scale temperature monitoring study con-
ucted in 10 refrigerators used to store vaccines at district and
ealth center facilities which showed persistent challenges in the
accine supply chain and indicated that 60% of the refrigerators had
∗ Corresponding author. Tel.: +33674932914; fax: +33674932914.
E-mail address: john.lloyd1945@gmail.com (J. Lloyd).
ttp://dx.doi.org/10.1016/j.vaccine.2014.10.080
264-410X/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article uhed  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/3.0/).
regular negative temperature excursions [5]. And while the EVM
assessment revealed that refrigerator temperatures were moni-
tored by standard thermometers twice a day as recommended,
freezing temperatures were frequently occurring in certain refrig-
erators and for prolonged periods [6]. Secondly, Tunisia’s national
immunization program has been equipping its districts and health
facilities with domestic refrigerators procured on the local mar-
ket in preference to pre-qualiﬁed, imported cold chain equipment.
Results from laboratory testing of the best performing domes-
tic models used in the country showed that these failed to meet
the norms 1 and standards set by the World Health Organization
(WHO) [7]. Thirdly, as Tunisia plans to introduce newer and more
1 “WHO/PQS Test Procedures E003/Guide 1.3: Failures at +32C and +43C tests (Day
Night, holdover,stable-running).
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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xpensive vaccines that are highly sensitive to freezing, a solution
o prevent vaccine freezing was urgently needed.
Against this backdrop, this paper describes the ﬁndings of
 demonstration that was a part of project Optimize—a WHO
nd PATH collaboration aimed at demonstrating transformational
olutions for vaccine supply systems in low and middle income
ountries [8]. This demonstration in Tunisia documents the impact
n accidental freezing incidence of introducing a continuous tem-
erature monitoring system and procedure into the vaccine supply
hain. The ﬁndings from this research will contribute to the evi-
ence based on new approaches and solutions to safeguard the
otency of vaccines in an end-to-end in-country vaccine supply
hain.
. Methods2
The methodology used for this research triangulated three
equential activities in a pilot region of Kasserine between the year
011 and 2012. The ﬁrst activity was to generate better evidence on
he performance of the cold chain system by conducting a baseline
ssessment of key temperature metrics. The second activity was  to
mplement a temperature monitoring solution in agreement with
he Ministry of Health in Tunisia. The third activity was  to measure
he impact of the solution against the same baseline assessment
emperature metrics. In the remainder of Section 2, each activity
ill be described in more depth.
.1. Baseline assessment
The Baseline assessment took place in 2011 for transport and
n January and February 2012 for storage. Temperature metrics of
torage were collected using two different approaches. The ﬁrst
as to track temperature in a ﬁeld setting and the second was to
rack temperature performance of the cold chain by testing various
odels of equipment in a laboratory setting. A specialized labo-
atory in Tunis conducted the tests according to WHO  norms and
rotocols. However, due to delays in testing, the results were not
vailable until April 2012 [9]. The 2011 temperature study in the
eld helped guide the selection of four refrigerator models assem-
led and available in the Tunisian market. The models with the
east energy consumption, corresponding to recent Government
egulations, and with a record of reliability in the district stores
nd health centers were chosen. Since all regional vaccine stores,
ere equipped with refrigerator models that met WHO/PQS norms
or storing vaccines (WHO prequaliﬁed), Kasserine regional store
quipment was not laboratory tested.
In the ﬁeld, standard stem or dial thermometers are used for
emperature monitoring and the practice for health workers is to
heck the thermometer temperatures twice daily, and manually
ecord the temperatures on a tracking sheet. Unfortunately, for
he purposes of this study, a thorough review of these tempera-
ure tracking sheets is not an effective way to gauge if inadvertent
reezing temperatures are occurring in the cold chain. As a rem-
dy, continuous recorded temperatures data was required for the
nalysis. As such, the baseline temperature assessment for vac-
ine storage was conducted for a two month period between
anuary and February 2012. Temperature data were collected using
2 The paper is based on the current WHO  Freeze alarm criteria (>60 consecutive
in  @ <−0.5 ◦C). −0.5 ◦C is the scientiﬁc freezing point of liquid vaccine. The actual
reezing point is not a stable reference point although it is in most cases well below
0.5 ◦C. Unfortunately, because below −0.5 ◦C the vaccines freeze point is variable
nd  unreliable, WHO  has the policy to check vaccines that have been exposed with
he  shake test, but not to expose vaccines below the alarm standard for storage. (2015) 902–907 903
continuous temperature recorders,3 conﬁgured to make readings
at 15 min  intervals and placed inside each refrigerator at the center
of the vaccine load. A total of 43 refrigerators were monitored as
follows: six refrigerators at the Kasserine regional store; one refrig-
erator each of the 12 district stores in Kasserine, and 25 health
centers located within the three key project districts of Feriana,
Foussana, and Hassi-el-Frid. For vaccine transport, the assessment
took place from September to November 2011 and was planned
to include two  for the Optimize project districts. The transport
leg between Kasserine regional store and two district stores were
tracked, and subsequently the leg between the two  districts and
the 25 health centers. A total of 31 deliveries to the health cen-
ters were assessed. Note that the standard practice in Tunisia is
to transport vaccines in domestic cooler boxes ﬁlled with frozen-
water packs without any temperature monitoring devices. For the
baseline assessment, the conﬁguration of temperature recorders
was reduced to a 5 min  interval to ensure there are sufﬁcient read-
ings for the shortest of the transport journeys monitored. In the
same manner as for refrigerators, the temperature recorders were
placed at the center of the vaccine load inside the cooler box.
For the analysis of the baseline temperature metrics, the data
from various temperature loggers were compiled and aggregated.
For storage in ﬁxed cold chain equipment, a total of 504,874
readings were made throughout the baseline reporting period.
For storage in mobile cold chain equipment, a total of 516 read-
ings were made along various transport routes, and retrieved for
analysis.
2.2. Implementing the vaccine freeze-prevention solution
In collaboration with the Ministry of Health at national and
local levels, a two-pronged approach to reduce the risk inadvertent
freezing in the vaccine cold chain of Tunisia was implemented in
the same facilities where the baseline assessment was conducted.
The demonstration was  conducted for a 6-month period between
March and September 2012. The ﬁrst approach was to introduce the
technology and practice of continuous temperature monitoring for
both vaccine storage and vaccine transport procedures. The sec-
ond approach was  to introduce new high performance containers
used to transport vaccine, and to switch to “Phase Change Mate-
rial” (PCM) packs. Each of the two  approaches is described in more
detail below.
2.2.1. Introducing continuous temperature monitoring of storage
and transport
In replacement of stem or dial thermometers with veriﬁca-
tion twice daily where research shows that this approach fails
to safeguard against damaging temperature excursions [10], con-
tinuous temperature recording devices were installed in the 43
refrigerators and for 30 vaccine transport journeys—a few more
than were assessed in the baseline. The same baseline conﬁgu-
ration for the temperature loggers was  kept so that comparisons
between the baseline and the demonstration temperatures could
be made. Visual temperature alarms setting were made accord-
ing to the WHO  time and temperature threshold as follows: a low
alarm would be triggered in the cold chain if temperatures were
at −0.5 ◦C or less for 60 consecutive minutes [11]. When a low
alarm is triggered, there is a high risk that vaccines would have lost
3 30-day temperature recorders meeting WHO/PQS Performance Speciﬁcation
E006/TR06.3: Models used in the Optimize study were: Storage – Log-tag TRED
30/7 with external temperature sensor. Transport – Log-tag TRID 30/7 with internal
temperature sensor. Conﬁguration of recorders in 2011 was not the same as in the
2012  baseline; in 2012 both the baseline and intervention recordings were made
with identical conﬁguration.
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age of 1.2 alarms per refrigerator per month and the overall trend
is downwards. The two  main reasons for this dramatic reduction
in alarms were that ﬁrst, some facility staff were unaware of the
problem when a simple solution existed (thermostat adjustment
4 PCM are a group of chemicals that can prevent freezing since they freeze andFig. 1. Design of the solution demonstrated.
heir potency from exposure to excessive freezing temperatures.
he control protocol is to conduct the “shake-test” when possible
12].
In addition to providing continuous temperature monitoring
evices, Standard Operating Procedures (SOPs) were developed for
ll health workers that would be managing or transporting vaccines
n the demonstration site. Health workers in the demonstration
ites were invited to follow training the temperature monitoring
evices; the procedures to follow in the event of an alarm (ex: how
o log the alarms and analyze root causes); and the method for
ransferring the monthly temperature data back up to the national
mmunization program in Tunis. The data would be centralized into
 national database for detailed analysis. In exchange, monthly tem-
erature reports were sent back to each of the demonstration sites.
hese were discussed during supervisory visits as a way  of building
apacity in the continuous temperature monitoring system.
.2.2. Using innovative cold chain technologies for transport
Following the steps of distribution in (see Fig. 1), transport
f vaccines in Tunisia is traditionally done in domestically pro-
uced picnic cooler boxes ﬁlled with frozen-water packs to keep
he temperatures in the correct ranges. Given that compliance for
onditioning ice-packs and adequately packing vaccines is limited
accines are often placed right next to, or on-top of a frozen water
ack. This practice increases the risk of vaccine freezing during
ransport. (2015) 902–907
For each of the demonstration sites that transport vaccines, high
performance cold boxes designed for temperature sensitive health
products were provided. The 15 h hold-over time of this equip-
ment exceeds the duration of any transport journey for vaccines
in the entire country. In addition, the standard frozen-water packs
were replaced with coolant packs ﬁlled with Phase Change Material
(PCM).4 The particularity of this PCM technology is that it can freeze
a positive temperature of +5 ◦C. Packs ﬁlled with PCM provide about
half of the cooling as a frozen-water pack but without the risk of
freezing.
In addition to providing continuous innovative cold chain
technologies for transport, standard operating procedures were
developed for all health workers transporting vaccines in the
demonstration sites. These health workers were invited to follow
the same training course on the temperature monitoring proce-
dures where an additional session on how to pack vaccines in these
new cold boxes was organized.
2.3. Measuring the impact
Measuring the impact of the solution to avoid inadvertent
freezing in the vaccine was  an exercise in comparing the tempera-
ture monitoring metrics measured during the baseline assessment,
against the monitoring of temperatures put in place as part of the
continuous temperature monitoring system implemented. For this
comparative analysis, key temperature indicators were generated
including the number of freeze alarms; the proportion of time vac-
cine were kept at the recommended ranges of +2 ◦C to +8 ◦C; and
the proportion of time temperature were under 2 ◦C. The analysis
of temperature was  conducted for both storage and transport.
3. Results
Signiﬁcant improvements were discovered (see Fig. 2 and
Table 1) when comparing the temperature performance of the cold
chain system before and after the implementation of the vaccine
freeze-prevention solution in the demonstration sites of the regions
of Kasserine in the South-Eastern part of Tunisia. These improve-
ments were noticed for cold chain storage at regional, district and
health center levels, and during the two transport legs that were
part of the demonstration.
3.1. Risk of freezing in storage reduced
In reviewing the ﬁndings from the baseline assessment of tem-
perature metrics (see Fig. 2), the analysis conﬁrmed the suspicions
that inadvertent freezing was occurring in storage. The temper-
ature data indicated a cumulative total of 335 freezing alarms
occurred during a two  month period between January and February
(the baseline for storage). These alarms occurred in 43 domes-
tic refrigerators that were part of the demonstration project—an
average of 3.9 alarms per refrigerator per month.
In spite of March being as almost as cold as February in Kasser-
ine, this baseline frequency of alarms was reduced to a total of 199
alarms during the four months (March–June) of the project, an aver-melt at a temperature threshold of +4◦C/+5◦C . If frozen in a refrigerator set to main-
tain +2◦C, they solidify over-night. (Salthydrate C7) PCMs have only half the Latent
heat  capacity (140 kj/kgK) than water-ice (334 kj/kgK) so they keep cool for a shorter
time.
J. Lloyd et al. / Vaccine 33 (2015) 902–907 905
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r respecting air movement spaces in the load). Second, where
he facility staff were aware of a problem requiring replacement
r repair, they were not able to engage the supervisors to tackle
he problem of inadequate performance or to take any action.
A more in-depth analysis of the baseline data highlighted two
ndings. The ﬁrst ﬁnding is that not all demonstration sites had
reeze alarms. The extent of the problem is least pronounced at
egional level and most pronounced at health center level. The bet-
er performance at regional level is due to the fact that in Tunisia
his level includes WHO  prequaliﬁed refrigerators. In the case of
asserine, of the four refrigerators use at the regional store, only one
s a domestic refrigerator, and the other three are WHO  prequaliﬁed
efrigerators for vaccines. For this reason, the temperature perfor-
ance at regional level was high—no freeze alarms and only 0.5%
f the time where temperatures dipped below +2 ◦C for two  rea-
ons. The ﬁrst is a seasonality effect and where these dips occurred
n the winter months were ambient temperatures in Kasserine are
nown to drop to freezing point, and where health facilities are
oorly insulated and/or have limited heating. The second reason is
hat the domestic refrigerator use at the regional store is the rea-
on why performance weakened during the demonstration period.
or the health center level ﬁndings, the poor temperature perfor-
ance is largely the result of the domestic refrigerators used. The
econd ﬁnding is that the relatively high incidence of alarms in
aseline and even project data, was concentrated around certain
rands of domestic refrigerators that were performing particularly
oorly, and putting vaccines at risk of potency damage and loss.
ross-checking the refrigerators brands with those tested in the
aboratory setting conﬁrmed that all were inadequate for storing
accines. While it is difﬁcult to know how the high incidence of
able 1
mpact of the vaccine freeze-prevention solution on temperature metrics at each level.
No. of freeze alarms 
Baseline Demonstration 
Regional level (x1) 0 0 
District level (x12) 6 0 
Health center (x25) 329 199 
Storage (overall) 335 199 
Transport (district to health centers) na na tion solution on vaccine storage at all levels.
freezing at health center level would have affected the potency of
the vaccines stored in those centers, it does beg the question of
whether damaged vaccines are being used.
Although freeze alarms are one temperature metric, the propor-
tion of time the temperatures were within the WHO  recommended
temperature ranges of +2 ◦C to +8 ◦C is an additional metric for
measuring the risk of inadvertent or accidental exposure to freez-
ing temperature. The analysis of this baseline temperature metrics
revealed that overall, the recommended temperature ranges were
maintained 73.9% of the time although this proportion would vary
by level. The recommended ranges were maintained 77.8% of the
time at district vaccines stores, and 63.2% of the time at health
facility level during the baseline assessment period.
When comparing the baseline temperature metrics against
those monitored throughout the implementation period of the
demonstration, we  ﬁnd signiﬁcant improvements the prevalence
of accidental exposure to freezing temperatures was signiﬁcantly
reduced. Subsequent to introducing the freeze prevention solu-
tion, the number of freeze alarms dropped signiﬁcantly to 116
alarms between March and April and 83 alarms between May  and
June. Another way to highlight the impact of demonstration is to
compare the monthly average of 167 alarms during the baseline
assessment against the 50 alarms per month during the demon-
stration phase. At district levels, freeze alarms dropped to zero
during the demonstration period while freeze alarms still occurred
at health center level but reduced by more than 40%. The percent-
age of temperature readings above +8 ◦C rose as a result of the use
of PCM packs by 5.4% which is not a signiﬁcant problem compared
to the risk of freezing when the maximum deviations do not exceed
+20 ◦C in transport.
% Temperature below 2 ◦C % Temperature between +2 ◦C to +8 ◦C
Baseline Demonstration Baseline Demonstration
0.5 2.3 96.3 91.7
15.5 1.0 77.8 83.1
33.6 10.8 63.2 82.5
23.9 8.9 73.9 83.9
13.8 1.7 59.9 65.7
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.2. Risk of freezing in transport reduced
The solutions implemented between district and health center
evels reduce the risk of freezing during the transport from 13.8%
uring the baseline (31 deliveries) to 1.7% during the demonstra-
ion (15 deliveries). This proportion did not drop to 0% as expected.
he residual 1.7% of < + 2 ◦C exposures were due to health worker
isunderstanding of PCM conditioning procedure following train-
ng. In some instances, the health workers put the PCM packs
n the freezer with tradition frozen water packs rather than in
 refrigerator. As a result, the PCM packs were deep frozen and
ould not operate in the way they are designed. Once this prac-
ice had been addressed by supervisory visits, compliance was
igh and there were no more occurrences of freezing during trans-
ort.
. Discussion
Tunisia, like many other middle income countries relies on
heaper and locally assembled domestic refrigerators and cold
oxes for storing and transporting vaccines. As discovered by
esting the better performing models in a laboratory setting, the
quipment used at the district and health center levels failed to
eet the minimum norms and standards set by WHO  for vaccines.
ll models showed important performance weaknesses that clearly
mpact on the quality of vaccine handling, equipment lifetime and
old chain reliability. One of these performance weaknesses is not
eing able to maintain the recommended temperature ranges of
2 ◦C to 8 ◦C and the risk of vaccine freezing. These weaknesses of
omestic refrigerators and the consequences when they are used to
tore vaccines are well known although few countries with refrig-
rator manufacture have sought a solution [13].
Given the risks, a temperature monitoring solution was imple-
ented in Tunisia and successfully demonstrated that the use of
lectronic/continuous temperature monitoring and freeze preven-
ion technologies can help signiﬁcantly to reduce the incidence of
nadvertent freezing of vaccine. Continuous monitoring of stor-
ge temperatures detected temperature excursions and freeze
vents even when health workers were not present. In addi-
ion, the ability to analyze the temperature data in real time
llowed health workers to take corrective action and speciﬁc
tandard operating procedures were put in place to help health
orkers respond appropriately. In addition to protecting the
otency of vaccines against freezing, the temperature monitor-
ng solution strengthened the cold chain equipment management
y detecting refrigerators that needed to be replaced or those
hose thermostat needed to be adjusted—something that was
ot possible when simple dial thermometers were use previ-
usly.
On vaccine transport, the practice of routine inspection of tem-
erature during distribution enabled health workers to ensure that
accines had not been compromised by the time they arrived
t destination. Temperature recording during transport further
ighlighted the beneﬁts of having a high performance storage
ontainer in association with PCM coolant packs that eliminated
ccurrences of freezing exposure. Poor compliance with the cur-
ent policy to pre-condition frozen water packs before loading
he vaccine into a cold box for transport were putting vaccines at
isk of freezing—particularly those closest to the un-conditioned
rozen packs. Removing need for pre-conditioning with PCM packs
lmost entirely removes the risk of freezing during transport
nd has important managerial beneﬁts from streamlining and
peeds up the process of preparing vaccines deliveries (no longer
he need for time-consuming pre-conditioning of frozen water
acks). (2015) 902–907
While this study provides evidence on the beneﬁts of imple-
menting freeze prevention solutions, several limitations are
noteworthy. The ﬁrst is that the solution implemented for stor-
age did not entirely mitigate all risks of freezing and highlights
that continuous temperature monitoring is a necessary but not
sufﬁcient intervention to prevent vaccine freezing when domestic
refrigerators are being used by the national immunization program.
The second is that for transport, the cost-effectiveness of using
PCM packs remains unclear. While this technology can eliminate
the risk of freezing during transport, it continues to be expensive.
In addition, the demonstration results showed that an additional
refrigerator is needed for cooling PCM packs. In theory, one of the
advantages of PCMs (beyond preventing freezing in a transport
cold box) was  that these could be cooled in the same refrigera-
tor that is use for storing vaccines, and thereby, eliminating the
need for health facilities to be equipped with a speciﬁc ice-pack
freezer. Unfortunately, the risk of heat exposure to vaccines from
cooling PCM packs in the same refrigerator is a concern and a sep-
arate refrigerator unit is required to store PCM packs. This adds
to the cost of implementing this solution. The third main limi-
tation concerns this analysis itself which is based on a relatively
short time series of 6 months. A full 12 months of data would have
provided sufﬁcient data to capture seasonality effects, and conﬁrm
the trends of lowering the incidents of freezing in the vaccine cold
chain.
Despite the limitations, the ﬁndings from this research have
important policy and practice implications. For countries that are
unable to purchase specialized vaccine cold chain, these ﬁndings
highlight the beneﬁts of switching to continuous temperature mon-
itor practices as a way  to safeguard the potency of vaccines in an
end-to-end in-country vaccine supply chain, and as a managerial
tool to ensure the continued effectiveness of national immunization
programs worldwide.
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